147 related articles for article (PubMed ID: 16858677)
1. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling.
Shi W; Bastianutto C; Li A; Perez-Ordonez B; Ng R; Chow KY; Zhang W; Jurisica I; Lo KW; Bayley A; Kim J; O'Sullivan B; Siu L; Chen E; Liu FF
Int J Cancer; 2006 Nov; 119(10):2467-75. PubMed ID: 16858677
[TBL] [Abstract][Full Text] [Related]
2. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway.
Zeng ZY; Zhou YH; Zhang WL; Xiong W; Fan SQ; Li XL; Luo XM; Wu MH; Yang YX; Huang C; Cao L; Tang K; Qian J; Shen SR; Li GY
Hum Pathol; 2007 Jan; 38(1):120-33. PubMed ID: 16996564
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma.
Faqing T; Zhi H; Liqun Y; Min T; Huanhua G; Xiyun D; Ya C
Exp Oncol; 2005 Jun; 27(2):96-101. PubMed ID: 15995625
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome meta-analysis reveals dysregulated pathways in nasopharyngeal carcinoma.
Tulalamba W; Larbcharoensub N; Sirachainan E; Tantiwetrueangdet A; Janvilisri T
Tumour Biol; 2015 Aug; 36(8):5931-42. PubMed ID: 25724187
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile changes and possible molecular subtypes in differentiated-type nonkeratinizing nasopharyngeal carcinoma.
Wang S; Li X; Li ZG; Lu J; Fang WY; Ding YQ; Yao KT
Int J Cancer; 2011 Feb; 128(4):753-62. PubMed ID: 20473882
[TBL] [Abstract][Full Text] [Related]
7. [Study on the expression of survivin mRNA and protein in nasopharyngeal carcinoma].
Fu SM; Wang YT; Tu ZH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):179-82. PubMed ID: 18393241
[TBL] [Abstract][Full Text] [Related]
8. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
[TBL] [Abstract][Full Text] [Related]
9. [Common dysregulated genes and pathways in two sets of nasopharyngeal carcinoma biopsy samples from differential regions].
XIONG YY; HUANG ZX
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):414-8. PubMed ID: 21421473
[TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients.
Yang S; Chen J; Guo Y; Lin H; Zhang Z; Feng G; Hao Y; Cheng J; Liang P; Chen K; Wu H; Li Y
Int J Oncol; 2012 May; 40(5):1590-600. PubMed ID: 22267178
[TBL] [Abstract][Full Text] [Related]
11. SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells.
Zhang W; Zeng Z; Wei F; Chen P; Schmitt DC; Fan S; Guo X; Liang F; Shi L; Liu Z; Zhang Z; Xiang B; Zhou M; Huang D; Tang K; Li X; Xiong W; Tan M; Li G; Li X
FEBS J; 2014 Nov; 281(21):4815-29. PubMed ID: 25161098
[TBL] [Abstract][Full Text] [Related]
12. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.
Alajez NM; Lenarduzzi M; Ito E; Hui AB; Shi W; Bruce J; Yue S; Huang SH; Xu W; Waldron J; O'Sullivan B; Liu FF
Cancer Res; 2011 Mar; 71(6):2381-91. PubMed ID: 21385904
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinoma.
Huang C; Tang H; Zhang W; She X; Liao Q; Li X; Wu M; Li G
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):166-75. PubMed ID: 22068284
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma.
Or YY; Chung GT; To KF; Chow C; Choy KW; Tong CY; Leung AW; Hui AB; Tsao SW; Ng HK; Yip TT; Busson P; Lo KW
J Pathol; 2010 Jan; 220(1):97-107. PubMed ID: 19718711
[TBL] [Abstract][Full Text] [Related]
16. Reexploring the possible roles of some genes associated with nasopharyngeal carcinoma using microarray-based detection.
Fang WY; Liu TF; Xie WB; Yang XY; Wang S; Ren CP; Deng X; Liu QZ; Huang ZX; Li X; Ding YQ; Yao KT
Acta Biochim Biophys Sin (Shanghai); 2005 Aug; 37(8):541-6. PubMed ID: 16077901
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of gp130 in nasopharyngeal carcinoma.
Lin YS; Lin LC; Huang MH; Huang AJ; Huang YT
Am J Rhinol Allergy; 2009; 23(1):28-32. PubMed ID: 19379608
[TBL] [Abstract][Full Text] [Related]
18. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways.
Liu L; Huang P; Wang Z; Chen N; Tang C; Lin Z; Peng P
BMC Cancer; 2016 Oct; 16(1):813. PubMed ID: 27756261
[TBL] [Abstract][Full Text] [Related]
20. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion.
Xia H; Ng SS; Jiang S; Cheung WK; Sze J; Bian XW; Kung HF; Lin MC
Biochem Biophys Res Commun; 2010 Jan; 391(1):535-41. PubMed ID: 19931509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
